Cellular Based Therapies for the Treatment of Multiple Sclerosis

QR Code

Cellular Based Therapies for the Treatment of Multiple Sclerosis

None

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Crooks, James, Zhang, Guang-Xian, Gran, Bruno
Hōputu:	Tāhiko Wāhanga pukapuka
Reo:	Ingarihi
I whakaputaina:	IntechOpen 2011
Ngā marau:	Health Sciences
Urunga tuihono:	https://www.intechopen.com/chapters/20676
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

Neuroimaging in Multiple Sclerosis
mā: Andreadou, Elisabeth
I whakaputaina: (2012)

Multiple Sclerosis and Celiac Disease
mā: Hernández-Lahoz, Carlos, me ētahi atu.
I whakaputaina: (2012)

Bowel Dysfunction in Persons with Multiple Sclerosis
mā: Gulick, Elsie E., me ētahi atu.
I whakaputaina: (2012)

E-Health 2.0 Developments in Treatment and Research in Multiple Sclerosis
mā: Jongen, Peter Joseph
I whakaputaina: (2012)

Mechanisms and Patterns of Axonal Loss in Multiple Sclerosis
mā: Harris, Zachary M., me ētahi atu.
I whakaputaina: (2012)

Cellular Therapy of ALL
mā: Moffa, Casey A., me ētahi atu.
I whakaputaina: (2011)

Cellular Therapies for Immunosuppression
mā: Cools, Nathalie, me ētahi atu.
I whakaputaina: (2012)

Effects of Anxiolytic Drugs in Animal Models of Multiple Sclerosis
mā: Novío, Silvia, me ētahi atu.
I whakaputaina: (2012)

Impact of Gray Matter Pathology on Cognitive Function in Multiple Sclerosis
mā: Andrea, Mike, me ētahi atu.
I whakaputaina: (2012)

Cellular Therapies for Huntington’s Disease
mā: Kelly, C. M., me ētahi atu.
I whakaputaina: (2012)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
mā: I. P. Ivanova, me ētahi atu.
I whakaputaina: (2021-10-01)

Cellular Immunotherapy Using Dendritic Cells Against Multiple Myeloma
mā: Lee, Je-Jung, me ētahi atu.
I whakaputaina: (2012)

Antibody-Proteases in the Pathogenesis of Autoimmune Demyelination and Monitoring Patients with Multiple Sclerosis
mā: Kostyushev, Dmitry, me ētahi atu.
I whakaputaina: (2011)

Immunomodulation of Potent Antioxidant Agents: Preclinical Study to Clinical Application in Multiple Sclerosis
mā: Fan, Shyi-Jou Chen Hueng-Chuen, me ētahi atu.
I whakaputaina: (2012)

Pathogenetic therapy of multiple sclerosis
mā: N. V. Komissarova, me ētahi atu.
I whakaputaina: (2023-09-01)

Diagnosis and Treatment of Giant Cell Arteritis (Temporal Arteritis) – Past, Current and Future Aspects
mā: Gran, Jan Tore
I whakaputaina: (2011)

MR Spectroscopy in Multiple Sclerosis - A New Piece of the Puzzle or Just a New Puzzle
mā: Aboul-Enein, Fahmy
I whakaputaina: (2012)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
mā: T. I. Yakushina
I whakaputaina: (2021-02-01)

The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.
mā: Elena Morandi, me ētahi atu.
I whakaputaina: (2017-01-01)

Tuberous Sclerosis Complex
mā: Sasongko, Teguh Haryo, me ētahi atu.
I whakaputaina: (2011)

Pulmonary Hypertension in Systemic Sclerosis
mā: Ghauri, Muhammad Ishaq, me ētahi atu.
I whakaputaina: (2011)

Blood Platelets and Systemic Sclerosis
mā: Lepreux, Sébastien, me ētahi atu.
I whakaputaina: (2012)

Apoptosis of T Lymphocytes in Systemic Sclerosis
mā: Szymanek, M., me ētahi atu.
I whakaputaina: (2012)

The features of reproductive health in women with multiple sclerosis
mā: O. A. Tikhonovskaya, me ētahi atu.
I whakaputaina: (2017-09-01)

Cellular Stress Responses
mā: Milisav, Irina
I whakaputaina: (2011)

Neurorehabilitation in complex treatment of multiple sclerosis
mā: I. A. Rybak, me ētahi atu.
I whakaputaina: (2008-12-01)

New therapy prediction technologies in multiple sclerosis
mā: V. I. Golovkin, me ētahi atu.
I whakaputaina: (2010-08-01)

Features of parameters of cellular immune depending on the activity of foci of demyelination in children with multiple sclerosis
mā: T. V. Radygina, me ētahi atu.
I whakaputaina: (2023-06-01)

The Use of a Hydrogel Matrix as a Cellular Delivery Vehicle in Future Cell-Based Therapies: Biological and Non-Biological Considerations
mā: Zarembinski, Thomas I., me ētahi atu.
I whakaputaina: (2011)

The Progression of Aortic Sclerosis to Aortic Stenosis
mā: Raslan, Uzma Jalal Serageldin, me ētahi atu.
I whakaputaina: (2011)

Proteasome Inhibitors in the Treatment of Multiple Myeloma
mā: Crawford, Lisa J., me ētahi atu.
I whakaputaina: (2012)

Capillary Dimension Measured by Computer Based Digitalized Image in Patients with Systemic Sclerosis
mā: Kim, Hyun-Sook
I whakaputaina: (2012)

Targeted Inhibition of Multiple Proinflammatory Signalling Pathways for the Prevention and Treatment of Multiple Myeloma
mā: Kannaiyan, Radhamani, me ētahi atu.
I whakaputaina: (2012)

Isolation of Cellular Clones of Murine Melanoma Resistants to the Photodynamic Therapy and Characterization of Some Mechanisms Involved in the Radioresistance
mā: E., Ramón-Gallegos, me ētahi atu.
I whakaputaina: (2011)

Polymer Based Therapies for the Treatment of Chronic Pain
mā: Dhal, Pradeep K., me ētahi atu.
I whakaputaina: (2012)

The role of autophagy in the pathogenesis and treatment of multiple sclerosis
mā: Giulio Righes, me ētahi atu.
I whakaputaina: (2025-12-01)

Cytokines in Systemic Sclerosis: Focus on IL-17
mā: Baraut, Julie, me ētahi atu.
I whakaputaina: (2012)

T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
mā: I. P. Ivanova, me ētahi atu.
I whakaputaina: (2014-07-01)

OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
mā: E. P. Evdoshenko, me ētahi atu.
I whakaputaina: (2014-07-01)

Recent Advances in Neuroimmunology, Diagnostics and Therapy of Multiple Sclerosis
mā: Helly Hammer, me ētahi atu.
I whakaputaina: (2025-03-01)